However, simultaneously, the recognition of the importance of IL‐2 for maintaining immune‐suppressive Treg has led to the somewhat counterintuitive strategy of treating some autoimmune conditions with low doses of exogenous IL‐2 summarized in Table 1. The gene discussed is IL2; the disease is Autoimmunity.